Conray 30 (Liebel-Flarsheim Company LLC)
Welcome to the PulseAid listing for the Conray 30 drug offered from Liebel-Flarsheim Company LLC. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Liebel-Flarsheim Company LLC |
NON-PROPRIETARY NAME: | Iothalamate Meglumine |
SUBSTANCE NAME: | IOTHALAMATE MEGLUMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
ROUTE: | INTRAVASCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-03-26 |
END MARKETING DATE: | 0000-00-00 |
Conray 30 HUMAN PRESCRIPTION DRUG Details:
Item Description | Conray 30 from Liebel-Flarsheim Company LLC |
LABELER NAME: | Liebel-Flarsheim Company LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/mL) |
START MARKETING DATE: | 2012-03-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0019-0952_e80407fa-3e59-461f-a0ab-c30384294c58 |
PRODUCT NDC: | 0019-0952 |
APPLICATION NUMBER: | NDA016983 |
Other IOTHALAMATE MEGLUMINE Pharmaceutical Manufacturers / Labelers: